United Therapeutics
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. (Founder, Chairman & CEO)
Mr. Michael I. Benkowitz (Pres & COO)
Mr. James C. Edgemond (CFO & Treasurer)
Summary
History
United Therapeutics was founded in 1996 by Martine Rothblatt, an American lawyer, author, and entrepreneur, who created Sirius XM. In 1994, Rothblatt's young daughter was diagnosed with a fatal orphan disease, pulmonary arterial hypertension . Rothblatt sold her telecom stock and started the PPH Cure Foundation to fund PAH research.In 2002, the U.S. Food and Drug Administration approved United Therapeutics' drug Remodulin, a prostacyclin vasodilator used to treat PAH. Remodulin provided PAH patients with an alternative to GlaxoSmithKline's Flolan. By 2003, Remodulin annual sales had reached $50 million. By 2010, annual sales were $300 million and United Therapeutics' share price had increased 800 percent from the 1999 initial public offering price.In 2011, United Therapeutics acquired Revivicor, a company focused on developing genetic biotechnology platforms to provide alternative tissue sources for treatment. In 2018, the company acquired SteadyMed, a medical device company developing injectable therapeutic drugs for pulmonary hypertension. Other acquisitions include SynQuest in 1999 and Cooke Pharma in 2000. United Therapeutics has entered numerous licensing agreements and collaborations with companies such as Eli Lilly and Company, Medtronic, DEKA Research & Development, and the National Cancer Institute. In March 2021, United Therapeutics’ market capitalization was $7.1 billion.On January 7, 2022, a porcine heart provided by United Therapeutics in conjunction with Kiniksa Pharmaceuticals and the University of Maryland Medical Center was used in the first pig-to-human transplant operation. The recipient subsequently passed away on Tuesday, March 8, 2022.
Mission
Vision
Key Team
Mr. Paul A. Mahon J.D. (Exec. VP, Gen. Counsel & Corp. Sec.)
Mr. Dewey Steadman C.F.A. (Head of Investor Relations)
Ms. Holly Hobson (Associate VP of HR)
Kevin T. Gray (Sr. VP of Strategic Operations & Logistics)
Mr. Patrick Poisson (Exec. VP of Technical Operations)
Mr. Gil Golden (Sr. VP & Chief Medical Officer)
Dr. Leigh Peterson (VP of Product Devel.)
Recognition and Awards
References
https://en.wikipedia.org/wiki/United_Therapeutics
https://in.investing.com/equities/united-therapeutics-corp
https://finance.yahoo.com/quote/UTHR/profile?p=UTHR
https://www.comparably.com/companies/united-therapeutics/mission
https://www.crunchbase.com/organization/united-therapeutics-unither
https://sec.report/CIK/0001082554
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. (Founder, Chairman & CEO)
Mr. Michael I. Benkowitz (Pres & COO)
Mr. James C. Edgemond (CFO & Treasurer)